Avid Bioservices Inc (CDMO)

[Protector]

Peregrine learns quickly!

The goal of this review is to gain a thorough understanding of the events leading up to, including and following the patient treatment group assignments and investigational drug coding and distribution. This review includes the testing of investigational product, patient samples, reviewing the operations of multiple vendors, among other activities.

They are reviewing the complete chain! That is why it takes time. They learned there lesson and are not only investigating the discrepancies but now check EVERYTHING (all data) of this trial, EVEN the data from BEFORE the patient treatment group assignments!

...the events leading up to, including and following...

Now say again they don't deserve their options! This is the ONLY PROFESSIONAL THING TO DO! Review it ALL no matter what to AVOID further 3rd party surprises! Good Peregrine!

UP 25% pre-market on about 400K shares! Good PR! Funding Fine Through Q3, Avid Record year and between the lines anticipating other funding. Step 1 on the recovery has been set and has been set well given the circumstances!